Previous research has illustrated that IGF2BP3 (IMP-3) overexpression is seemingly restricted to several epithelial malignancies correlated with aggressive behavior and lymphomas originating from physiologic germinal center B cells. The gene discussed is IGF2BP3; the disease is lymphoma.